ZA903258B - Method of suppressing hiv infection - Google Patents

Method of suppressing hiv infection

Info

Publication number
ZA903258B
ZA903258B ZA903258A ZA903258A ZA903258B ZA 903258 B ZA903258 B ZA 903258B ZA 903258 A ZA903258 A ZA 903258A ZA 903258 A ZA903258 A ZA 903258A ZA 903258 B ZA903258 B ZA 903258B
Authority
ZA
South Africa
Prior art keywords
hiv infection
suppressing hiv
suppressing
infection
hiv
Prior art date
Application number
ZA903258A
Inventor
Donald C Anderson
C Anderson Donald
Wayne C Smith
C Smith Wayne
Robert Rothlein
Rothlein Robert
Robert Eckner
Eckner Robert
Roger D Rossen
D Rossen Roger
Original Assignee
Baylor College Medicine
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College Medicine, Boehringer Ingelheim Pharma filed Critical Baylor College Medicine
Publication of ZA903258B publication Critical patent/ZA903258B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2821—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against ICAM molecules, e.g. CD50, CD54, CD102
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70525—ICAM molecules, e.g. CD50, CD54, CD102
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • C07K14/70553—Integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2845—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA903258A 1989-04-28 1990-04-27 Method of suppressing hiv infection ZA903258B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34486889A 1989-04-28 1989-04-28

Publications (1)

Publication Number Publication Date
ZA903258B true ZA903258B (en) 1991-02-27

Family

ID=23352400

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA903258A ZA903258B (en) 1989-04-28 1990-04-27 Method of suppressing hiv infection

Country Status (3)

Country Link
AU (1) AU5568290A (en)
WO (1) WO1990013281A2 (en)
ZA (1) ZA903258B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991018010A1 (en) * 1990-05-15 1991-11-28 Swinburne Limited Inhibition of viral infection using intercellular adhesion molecule-1-like peptides and/or analogues thereof
US6129916A (en) * 1991-04-19 2000-10-10 Tanox, Inc. Method of Increasing activation on proliferation of T cells using antibody-microbead conjugates
CA2065658A1 (en) * 1991-04-19 1992-10-20 Tse-Wen Chang Conjugates of liposomes or microbeads and antibodies specific for t lymphocytes and their use in vivo immune modulators
US6197298B1 (en) 1991-04-19 2001-03-06 Tanox, Inc. Modified binding molecules specific for T lymphocytes and their use as in vivo immune modulators in animals
US5872222A (en) * 1991-04-19 1999-02-16 Tanox Biosystems, Inc. Conjugates of polymers and antibodies specific for T lymphocytes, and their use as adjuvants
US6106835A (en) * 1991-04-19 2000-08-22 Tanox, Inc. Modified binding molecules specific for T or B lymphocytes and their use as in vivo immune modulators
US6534057B2 (en) * 1993-03-19 2003-03-18 Allen D. Allen Method increasing the delayed-type hypersensitivity response by infusing LFA-1-specific antibodies
AU6256796A (en) * 1995-06-06 1996-12-24 D. Allen Allen Method for treating molluscum contagiosum resulting from hiv infection
DE60042069D1 (en) 1999-06-24 2009-06-04 Univ Johns Hopkins COMPOSITIONS AND METHODS FOR PREVENTING TRANSPITHELIAL TRANSMISSION OF HIV
JP2008507592A (en) 2004-06-09 2008-03-13 ジェネンテック・インコーポレーテッド Treatment of annular granulomas or sarcoids
WO2007047573A2 (en) * 2005-10-14 2007-04-26 The Johns Hopkins School Of Medicine Reduction and prevention of cell-associated hiv transepithelial migration, microbides and other formulations and methods

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0303692A4 (en) * 1987-02-26 1990-12-05 Dana Farber Cancer Institute Cloning of lfa-1
ES2080044T3 (en) * 1987-05-04 1996-02-01 Dana Farber Cancer Inst Inc INTERCELLULAR ADHESION MOLECULES AND THEIR FIXATION LINKS.

Also Published As

Publication number Publication date
AU5568290A (en) 1990-11-29
WO1990013281A3 (en) 2004-04-22
WO1990013281A2 (en) 1990-11-15

Similar Documents

Publication Publication Date Title
OA09030A (en) Method of selectively inhibiting hiv
US5111871B1 (en) Method of vacuum casting
PL286707A1 (en) Method of obteining tetraniture
EP0407452A4 (en) Method of treating retrovirus infection
ZA903258B (en) Method of suppressing hiv infection
EP0472595A4 (en) Method of treatment of hepatitis
EP0414569A3 (en) Three-liquid-phase epoxidation of perfluoroolefins
EP0472663A4 (en) Method of treatment of hepatitis
ZA904311B (en) Method of preparing n-oxo-tetrahydro-beta-carbolines
SU1670858A1 (en) Method of blood drawing
EP0416577A3 (en) Method of preparing levoglucosenone
CS51189A2 (en) Method of 1-methoxy-2-propanone preparation
GB8916394D0 (en) Method of treatment
CS279089A1 (en) Method of 1-amino-7-naphthol preparation
CS3889A1 (en) Method of yeast /1-3/-beta-d-glucan purification
CS717389A1 (en) Method of optically active 2-deoxy-l-ribose preparation
IE892878L (en) Method of treating viral infections
CS35489A1 (en) Method of normethanephrine preparation
CS214389A1 (en) Method of lysinesalicylate preparation
CS23489A1 (en) Method of z-alkenes preparation
CS275569B2 (en) Method of concentrated alkylpolyglycoletersulfates preparation
ZA889498B (en) Method of inhibiting virus
ZA889496B (en) Method of inhibiting virus
CS741889A2 (en) Method of alkylsubstituted guanidiniumnitrates preparation
ZA908094B (en) Treatment of hiv infections and compounds useful therein